Rémi Droller

Rémi Droller is the Managing Partner and Président du directoire at Kurma Partners, a life sciences venture capital firm based in Paris, France. He began his investment career in 2000 at CDC Innovation before leading life sciences investments at AGF Private Equity from 2003 to 2010. Since joining Kurma in 2010, Droller has overseen a portfolio of approximately 60 healthcare companies and recently helped secure a €140 million first close for Biofund IV. He has been instrumental in creating around 12 biotechnology startups and guided portfolio companies through major transactions, including the acquisition of ImCheck Therapeutics by Ipsen. Under his leadership, Kurma Partners was fully integrated into Eurazeo, an investment group managing €36 billion in assets, in April 2025. His current focus centers on financing early-stage European biopharma, diagnostics, and digital health ventures from inception through clinical proof-of-concept.